SYS ONLINE
Supplements/Compound

Lactobacillus plantarum 299v

Single-strain probiotic with the strongest IBS evidence.

Buy

Overview

Single-strain probiotic with the strongest IBS evidence.

Natural sources
  • Endogenously produced or biosynthesized molecule
  • Standardized pharmaceutical- or food-grade supplement
  • Combined with cofactors that improve absorption or activity
Common forms
  • Capsule or softgel
  • Powder
  • Sublingual or buccal
  • Liposomal liquid

Forms & variants of Multi-Strain Probiotic

Different chemical forms of Multi-Strain Probiotic behave differently. Browse each form's mechanism, bioavailability, and best-use context.

Mechanism of action

Adheres to mannose receptors on enterocytes; produces short-chain fatty acids.

Pathways
  • · Adheres to mannose receptors on enterocytes
  • · produces short-chain fatty acids

Effects on the body

Decreases
IBS pain and bloating

Organ system effects

Evidence-based benefits

Reduces IBS pain and bloating

Strong evidence

Potential side effects

Common
  • · Initial bloating
Rare
    Serious

      Drug interactions

      Prescription medications (general)
      Always disclose Lactobacillus plantarum 299v use to your prescriber — additive, antagonistic, or pharmacokinetic interactions are possible.
      minor

      Supplement interactions

      Pairs well with
      • A high-quality multivitamin
        Covers micronutrient cofactors that support most supplement pathways.
      • Omega-3 (EPA/DHA)
        Foundational anti-inflammatory support that complements most regimens.
      Avoid combining with

      No specific avoidances listed.

      Dosing & bioavailability

      Typical dose
      10 billion CFU
      Best form
      Most evidence is based on the capsule or softgel form.
      Timing
      Consistent daily timing recommended; split larger doses if GI tolerance is a concern.
      With food?
      With meals

      Where to buy

      Affiliate links — we may earn a commission at no extra cost to you. Amazon code supplementsch-20 is auto-applied at checkout. We don't endorse specific brands; verify third-party testing (USP, NSF, Informed Sport) before purchase.

      Scientific evidence8Show studies
      RCTWorld J Gastroenterol · 2012

      L. plantarum 299v in IBS

      Ducrotté P, et al.

      4-week DB-RCT in 214 IBS patients.

      Key findings

      Significantly reduced abdominal pain and bloating vs placebo.

      Open study
      Systematic reviewPubMed (NLM) · 1970

      PubMed: Lactobacillus plantarum 299v — Reduces IBS pain and bloating

      Live PubMed search

      Live results for "Lactobacillus plantarum 299v Reduces IBS pain and bloating" across the PubMed/MEDLINE peer-reviewed index.

      Key findings

      Opens current human and preclinical literature matching Lactobacillus plantarum 299v and "Reduces IBS pain and bloating". Filter by RCT, meta-analysis, or year on the results page.

      Open study
      Systematic reviewPubMed (NLM) · 1970

      PubMed: Lactobacillus plantarum 299v — randomized controlled trial

      Live PubMed search

      Live results for "Lactobacillus plantarum 299v randomized controlled trial" across the PubMed/MEDLINE peer-reviewed index.

      Key findings

      Opens current human and preclinical literature matching Lactobacillus plantarum 299v and "randomized controlled trial". Filter by RCT, meta-analysis, or year on the results page.

      Open study
      Systematic reviewPubMed (NLM) · 1970

      PubMed: Lactobacillus plantarum 299v — meta-analysis

      Live PubMed search

      Live results for "Lactobacillus plantarum 299v meta-analysis" across the PubMed/MEDLINE peer-reviewed index.

      Key findings

      Opens current human and preclinical literature matching Lactobacillus plantarum 299v and "meta-analysis". Filter by RCT, meta-analysis, or year on the results page.

      Open study
      Systematic reviewPubMed (NLM) · 1970

      PubMed: Lactobacillus plantarum 299v — pharmacokinetics

      Live PubMed search

      Live results for "Lactobacillus plantarum 299v pharmacokinetics" across the PubMed/MEDLINE peer-reviewed index.

      Key findings

      Opens current human and preclinical literature matching Lactobacillus plantarum 299v and "pharmacokinetics". Filter by RCT, meta-analysis, or year on the results page.

      Open study
      Systematic reviewPubMed (NLM) · 1970

      PubMed: Lactobacillus plantarum 299v — safety adverse events

      Live PubMed search

      Live results for "Lactobacillus plantarum 299v safety adverse events" across the PubMed/MEDLINE peer-reviewed index.

      Key findings

      Opens current human and preclinical literature matching Lactobacillus plantarum 299v and "safety adverse events". Filter by RCT, meta-analysis, or year on the results page.

      Open study
      Systematic reviewPubMed (NLM) · 1970

      PubMed: Lactobacillus plantarum 299v — dose response

      Live PubMed search

      Live results for "Lactobacillus plantarum 299v dose response" across the PubMed/MEDLINE peer-reviewed index.

      Key findings

      Opens current human and preclinical literature matching Lactobacillus plantarum 299v and "dose response". Filter by RCT, meta-analysis, or year on the results page.

      Open study
      Systematic reviewGoogle Scholar · 1970

      Google Scholar: Lactobacillus plantarum 299v — clinical evidence

      Live Scholar search

      Cross-database citation index for Lactobacillus plantarum 299v as it relates to "clinical evidence".

      Key findings

      Includes preprints, theses, and journal articles. Useful for tracking citation counts and follow-on work.

      Open study
      Educational use only. This profile is not medical advice. Consult a qualified healthcare professional before starting any supplement, especially if you take prescription medication or have a chronic condition.

      Community discussion

      (0 threads)

      Share your experience or read what others have tried. Anecdotes are not medical advice.

      Sign in or create a free account to post or reply.
      Loading discussion…